Followers | 226 |
Posts | 5,049 |
Boards Moderated | 0 |
Alias Born | 03/15/2010 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know... good luck
@some point...up she goes
withlove
I want some Cheapies too
10-K AH
$TRTC
Guess you're in need
here's some good sh$t... here's a link: http://ivxx.com/?age-verified=60f2ce79a2
Good luck
IVXX is now Available at Premier San Francisco Medical Cannabis Dispensary
Oakland, March 25, 2015 (GLOBE NEWSWIRE) -- Terra Tech Corp (TRTC), is pleased to update shareholders on the launch and continued development of IVXX branded cannabis products. The Company is proud to announce that their brand of exceptional quality cannabis products is now available in San Francisco at the The Green Door. The Green Door is one of San Francisco's premier medical cannabis facilities. They have tirelessly served the patient community since 2005.
"We are thrilled that the IVXX brand is now available to patients in San Francisco. The Green Door has offered the highest level of service and medicine to patients for the last decade," explains Derek Peterson, CEO of Terra Tech. "We are pleased that our IVXX extracts meet the rigorous standards for quality, consistency and efficacy they demand for their patients. Demand has exceeded our expectations and we are working diligently to increase both production as well as product offerings."
IVXX products are only available to qualified patients through permitted medical cannabis dispensaries that are in full compliance with California Prop 215, SB 420 sections 11362.5 & 11362.7 of HSC. The company is also launching a full website, IVXX.com, in support of the brand. Through the website, patients and brand enthusiasts will be able to learn more about the products offered by IVXX, find local retailers, as well as purchase IVXX branded gear. The Oakland-based lab will be producing all of the concentrates for IVXX.
The Company will issue additional updates to investors in the near future.
http://money.cnn.com/news/newsfeeds/articles/globenewswire/10126406.htm
$TRTC
FEDERAL COURT ~ FILING T-262-15 - February 20, 2015
Same date February 20, 2015~ LOL
Statement from Health Canada
February 20, 2015
$FITX
CEN BIOTECH: SO GOOD THEY CAN'T IGNORE YOU
http://seekingalpha.com/instablog/822743-rise51/3839386-cen-biotech-so-good-they-cant-ignore-you
$FITX
http://cenbiotechinc.com/PlatformApps/CEN/c1/faq.html
FAQ
Why doesn’t the company show the inside of the facility?
Under the MMPR, it would be a violation of security.
Does CEN Biotech intend to spinoff and uplist to a higher exchange?
CEN Biotech Inc. has given notice of its intent to spinoff CEN Biotech Inc. from Creative Edge Nutrition, Inc. It has hired a PCAOB auditor and is far into its audit. CEN Biotech intends to be a fully audited and fully reporting company.
CEN Biotech, because of its spin-off from Creative Edge and its subsequent plans to be a new publicly-traded company (as announced in THIS PRESS RELEASE
Why was the pre-license inspection report made public?
A known shareholder to the company did a Freedom of Information Act request and received from the Privacy Commissioner under the Authority from Health Canada the full inspection report. So as to not allow this shareholder sensitive inside information, CEN Biotech, Inc. immediately released the inspection report per their legal obligations to the SEC.
The press release states clearly: “As CEN Biotech Inc. continues in its effort to be transparent, it releases its Health Canada Pre-License inspection report." The report can be viewed HERE. The press release can be viewed HERE.
To address your concern around our inspection report being released; that report was never provided to us after inspection by Health Canada. A shareholder filed a Freedom of Information Request with the Office of Privacy Commissioner to obtain that report. Once that report was released under the scrutiny of the Privacy Commissioner, in full, it was considered public domain; such as other media outlets rely on in their reporting of facts. We were confused as to why Health Canada refused to provide us with the report and we were apprised of the result of the inspection by a shareholder. Only at that time, was CEN Biotech sent a copy of what was intended to be released via FOIA. As a matter of fact, Bill Chaaban denied the request to release any of the information, but was advised by Ms. Vicky Straby that the report had to be released. Once that report was disseminated to one shareholder or individual outside the company, Securities law dictated the company and Mr. Chaaban as its CEO was legally responsible to immediately disseminate so as to NOT promote insider trading or an unequal opportunity via market trading. The report had to be disseminated so-as not to put him in a position of liability for providing insider information due to Heath Canada’s actions. In fact, Health Canada released a press release in regards to releasing pharmaceutical inspections publicly in an attempt to transparency.
Did any officers or employees of CEN Biotech claim to have special access to the Minister or employees at Health Canada?
Roger Glasel personally replied to these allegations directly to the Ministers office as follows: “My involvement with the Minister's activities were peripheral and limited to her constituency office's efforts at citizen involvement, locally. This was in 2010, long before she was appointed to her current portfolio. If anything, I made CEN aware of that brief involvement in Minister Ambrose’s constituency office ahead of participating in the company, for the purposes of disclosure so CEN Biotech Inc. could vet any potential conflict.”
Not I, nor anyone in this company, ever represented that CEN Biotech Inc. had special access to the Minister or anyone at Health Canada. The rate and progression of our application would be evident proof of our claim.
Why did the company use a nom du plume for Roger Glasel?
Company officers and employees have received multiple death threats and threats of physical harm via email and telephone and person visits (some of which have been saved by the Company). Police reports have been made with the appropriate law enforcement agencies. Health Canada was appraised of these death threats via email on December 19, 2014. The email follows:
On December 19, 2014, we notified the Office of the Controlled Substances via email that “As the CEO of a public company, I am being personally harassed, threatened, slandered and defamed because of the time it has taken for our company to complete this process. I do not write to you seeking special treatment, I write to requesting a timeline on when our license will be issued or most importantly the Issuance of our license.”.
Bill Chaaban and our company had received in excess of one dozen emails and numerous phone calls threatening bodily harm. Reports were made to the appropriate law enforcement departments. It is this very reason why a nom du plume was chosen to protect the life of our executive team and their families.
Where did the company get timelines for pre-license inspection?
CEN Biotech was given timelines for inspection via email from Health Canada. CEN Biotech was told by Health Canada officials via email that inspections would be conducted one to two weeks after a call for inspection. This was materially false as it took three months.
Why wasn’t CEN Biotech issued a conditional license?
We felt, from our perspective, we did everything reasonable to ensure we addressed any concern, or requirement, even if those requirements were not required by other LP applicants. We feel that Health Canada, at any time, could have and should have, issued a conditional license pursuant to Section 25(k), since at least June of 2014, and gave CEN Biotech Inc. some indication on final steps, if any, were required.
Does CEN Biotech have the proper zoning?
On the issue of the Town of Lakeshore, we have been very prudent to ensure that Health Canada knew that their untimely decision to attempt to exempt our facility is of grave concern, especially when a “Ready to Build” letter was issued and all parties agreed there were no issues around zoning at time of construction and substantial investment. (Please see HERE for the Minutes of the Lakeshore 11/12/13 Town Council meeting on page 31-32 which documents that zoning was proper resulting in a “Ready to Build” letter).
We were provided a letter confirming our position that our lands and buildings, with associated permits, et al was IN FACT in conforming use and legal in the aspects of the Chief Building Official, Morris Harding on October 8, 2014 and was also forwarded to the MMPR officials. Key points are the property was zoned properly and in accordance with the Town of Lakeshore Zoning By-Law Number 2-2012.
On February 24, 2015 in the Windsor Star, Steve Salmons, Director of Community Development was quoted as confirming precisely our argument, medical marijuana is a crop, and as such is to be on agricultural land. A move of a facility like ours to industrial will only endanger the quality of the plant, and the end quality to the patient. Article can be found HERE.
To quote Mr. Salmons, “...The property is zoned agricultural,” he said. “Everything they have done so far – even though it might be visually unappealing – is legal as a farming operation. Farms can put up fences or agricultural buildings like a pole barn.”
The land upon which the premises are located are zoned “Agricultural”:
•Lakeshore Comprehensive Zoning By-Law s. 4(5)
•October 8, 2014 correspondence from Morris Harding
•November 12, 2013 memo from Administration (Salmons and Foran) to Lakeshore Town Council
•“Processing” of medical marihuana is not an allowed activity under the MMPR, so no processing or “value added” may be done to the crop. It must be grown, harvested and sold
No Authorizations are necessary to grow harvest or sell a crop in an “Agricultural” zone. Site Plan Approval must be made if there is Value added, which is includes “a use accessory to an agricultural use, used for the processing and refining of crops and produce....”
•Lakeshore Comprehensive Zoning By-Law s. 4(6)
Lakeshore passed new By-Laws and Official Plan Amendments on November 25, 2014. The by-Laws and Official Plan Amendment have not been approved by the County. As the facilities have been built for the purpose of a Medical Marihuana Facility, the new by-laws cannot be applied retroactively. Please see the doctrine of legal non-conforming use.
•Central Jewish Institute v. Toronto, [1948] 2 D.L.R. 1 (S.C.C.)
•Saint-Romuald (City) v. Olivier, [2001] 2 SCR 898 (S.C.C.)
Confusion between Town of Lakeshore and Health Canada surround comments made by Bill Chaaban. Mr. Chaaban wrote to HC on October 8, 2014 indicating:
•“As per your request, a letter dated today, October 8, 2014 whereby the Town of Lakeshore confirms, in writing, we are properly zoned with no issues reported by the Chief Building Official, Morris Harding, whom is the official recognized under the Municipal Act.
Mr. Foran, for the Town, wrote to HC on October 15, 2014:
•“The advice provided to you in the October 8th correspondence from CEN Biotech Inc. to the effect that the property is appropriately zoned with no issues relating to the use of that property for medical marihuana production facilities is simply incorrect”
The Applicant submits that they provided accurate information to HC, based on the statements and letters of Town officials. Mr. Foran appears to have misquoted Mr. Chaaban’s words.
Reference correspondence from CEN dated October 19 & 29, 2014 and from Baksh to HC dated October 30, 31 and November 6, 2014.
It is the Applicant’s position that there is no issue as to proper zoning or authorizations to operate the business of a medical marihuana facility on the site.
HC letter - "These unresolved issues lead to concerns about appropriate municipal services being in place."
•The level of municipal services presently in place will be adequate to run the facility. There are no issues as to water, sewage or electrical consumption
•CEN letter to HC dated November 18, 2014 with attachments.
Does CEN Biotech have the proper municipal services?
Also, to quote, the ‘Town Administrator’, “…the property doesn’t have the water, hydro and sewage services that will be needed to support a facility which was touted to annually produce 600,000 kilograms of medical marijuana….”. However, we can honestly state on the record that our organization has been refused ANY further permits, pending Lakeshore counsel’s legal approval of every single permit since the time the amendment was passed in November, 2014 preventing our land use rights to develop the property properly to accommodate any further requirements of the municipality, or that of the facility. We submitted our business plan and third party engineering reports evidencing our proposed build-out to the 600,000kg capacity.
Did CEN Biotech Rely on Statements made by Health Canada officials?
When relying on the Affidavits of Todd Cain, also of Health Canada, I depose the following facts extracted from his sworn and duly filed affidavits:
1.CEN Biotech relied on assurances and statements made by Health Canada employees. In particular, the timeline given regarding how soon an inspection to take place after it is called and the issuance of a license after the inspection has been conducted. CEN Executives utilized this time line to raise funds to build and operate the facility.
2.Todd Cain stated in his affidavit dated Feb 7, 2014 that he “worked with the Licensing and Permits team to streamline the application process to make it accessible to potential applicants for production licenses” (emphasis added). It appears that this streamline process was not equally afforded or applied to all applicants in the process; especially not CEN Biotech.
3.In his affidavit, Todd Cain stated “one of the primary strategies has been to conduct an information campaign for production licenses under the MMPR. The goal of this campaign was to generate awareness among potential applicants for production licenses and businesses who could support them, about the legitimate business mode created by the MMPR.” CEN has the ability to operate as a viable LP but was unfairly refused to do so by Health Canada.
4.In his affidavit, Todd Cain stated that Health Canada had created “streamlined processes for processing applications”. Upon information and belief, CEN relied on this statement and watched other LP’s as they progressed to full licensing. CEN was never afforded the opportunity to a streamlined process.
5.Todd Cain stated in his affidavit, a case management plan was created for triaging applications for production licenses, “this triage system was created to foster efficient and appropriate approval of qualified applicants and start-up of Licensed Producers. CEN was not afforded this opportunity.
6.Todd Cain stated in his affidavit that “a case management approach was also adopted, which involves appointment of case managers to work with applicants to compete the review process and to enhance timely processing of applications.” CEN was NEVER to its knowledge assigned a case manager.
7.Todd Cain stated in his affidavit, “Providing applicants with “Ready to Build” letters, upon the completion of the paper review process, upon request. These letters advise applicants that if they complete their site build as described in their application, if the site is verified by a pre-license inspection, and if security clearances are granted, the applicant’s license can be issued. This letter is intended to provide applicants with the documentation they may use to make necessary financial and other business-related arrangements”. CEN fulfilled all of its obligations and met the requirements as set out under the MMPR.
8.Todd Cain stated in his affidavit, Health Canada is “Providing a “phased licensing process”: If an applicant has completed the paper review and met the regulatory standards for cultivation of dried marihuana”. Health Canada has NEVER afforded the opportunity to CEN for a phased licensing process. CEN asked Health Canada months ago for a phased license and was denied without reason.
We, as an organization, can safely say we were never afforded the same opportunities as others in the MMPR program; clearly by our timeline of events alone.
Will Creative Edge Nutrition, Inc. do a reverse in 2015?
No there are no plans to do one in 2015. http://finance.yahoo.com/news/creative-edge-nutrition-inc-ceo-120000433.html
$FITX
BID 1, ASK 2
That's all that matters...making $$$$$$$$
More to come IMO
Go FITX
Capricious Actions by Health Canada Causing Detrimental Reliance to MMPR Applicants
"Under the compelling of mandamus, Health Canada has 10 days to respond by either issuing a license to CEN Biotech, or opposing the application in federal court. This deadline is upon us."
http://www.mmj.today/capricious-actions-by-health-canada-causing-detrimental-reliance-to-mmpr-applicants/
$FITX
Medical marijuana grower with track record wants to cultivate pot in Central New York
http://www.syracuse.com/health/index.ssf/2015/03/post.html
$TRTC
I hope so too...
nope... the world doesn't know
http://ih.advfn.com/p.php?pid=news&symbol=NO%5EBTZO
CEN Biotech to fight medical marijuana licence rejection in court
http://blogs.windsorstar.com/news/cen-biotech-to-fight-medical-marijuana-licence-rejection-in-court
A group behind a proposed medical marijuana operation in Lakeshore is taking the federal government to court.
CEN Biotech has applied for a federal judicial review after Health Canada earlier issued a notice it intended to deny the company’s application to operate a medical marijuana facility. The company has called the government’s position “unlawful or unreasonable.”
CEN Biotech accuses Health Canada of acting beyond its jurisdiction and without procedural fairness, according to court documents filed in Toronto.
The federal department is also accused of “breaching confidentiality” by forwarding correspondence to third-parties, including the town of Lakeshore, a move which it claims harmed the company’s standing.
.
.
.
$FITX
aah, ok
Acquisitions...
$FITX WOW...this is serious stuff!!!!
FEDERAL COURT ~ FILING T-262-15 - February 20, 2015
CEN BIOTECH: THE THIN RED LINE
http://seekingalpha.com/instablog/822743-rise51/3762426-cen-biotech-the-thin-red-line
CEN Biotech Files Application for Judicial Review – UPDATED
http://www.mmj.today/cen-biotech-files-application-for-judicial-review/
$FITX
CEN BIOTECH: THE THIN RED LINE
http://seekingalpha.com/instablog/822743-rise51/3762426-cen-biotech-the-thin-red-line
$FITX
Thank you for your opinion.
CEN Biotech Files Application for Judicial Review
CEN Biotech Files Application for Judicial Review and is seeking discovery.
-Health Canada Has 10 days to oppose Mandamus or issue a license under MMRP
-CEN Biotech and other applicants treated unfairly
-CEN Biotech requested to accelerate build out, receiving no license
CEN Biotech Inc. has filed application for judicial review through the federal courts in Ontario against the office of the Minister of Health in regards to a delay and/or failure of decision in issuing a Medical Marijuana grow license under the Canadian MMPR program. CEN Biotech has provided a timeline of unique key events in this filing which outline grave misrepresentation of the intent of Health Canada towards the programs largest applicant. Including, but not limited to, requesting that the company accelerate build out of its production facility for a provisional license in order to meet patient demand, which cost the company a significant amount of money.
The office of the Minister of Health has recently served CEN Biotech with intent to reject the company’s license application within 20 days if sufficient evidence cannot be presented within that timeframe to justify a decision to the contrary. CEN Biotech has responded loudly with exactly that, and outlines that full protocol has been maintained and all requirements for licensing have been met or exceeded by CEN Biotech in accordance with the MMPR regulations and Health Canada’s instructions.
The federally filed application for judicial review orders that Health Canada issue the agreed upon license to CEN Biotech within 10 days for their site on manning road, or must oppose this application in Federal court. Failure to oppose this application will result in a potential judgment being given by the courts in their absence, in favor of CEN Biotech.
The federal application filed declares that the refusal of license is unlawful, unreasonable, or both. It also applies for an order of mandamus, pursuant to section 25 of the MMPR, which would compel the Licenses and Permits Division of Health Canada, or the Minister of Health to issue the license.
The application also requests an order of prohibition against the Minister of Health and the MMPR to prevent further interference and breach of duty and unlawful decisions against CEN Biotech, as well as an order for Health Canada to pay costs to CEN Biotech Inc.
CEN Biotech maintains that they have made all reasonable attempts to receive a license and have followed all required steps and instructions and that there is an “identifiable” and critical issue in Health Canada’s lack of diligence.
Health Canada has caused unjust delay by interfering with cross jurisdictional matters such as legal non-conforming use of lands, and has displayed a lack of clear and concise communication which has caused unjust prejudice through the process, even having gone so far as to be completely unresponsive toward CEN Biotech while breaching confidentiality by forwarding confidential correspondence to Lakeshore and others.
CEN Biotech was asked for an accelerated build out, which was given. They were also inspected and advised they would receive a license within 1 to 2 weeks after inspection. After this, the communication appears to fall apart at Health Canada completely, about the time Jacinthe David becomes involved in communications with CEN Biotech. Jacinthe is the manager of the Licensing and Permits division, at the Office of Controlled Substances. Prior to this, CEN Biotech appears to be communicating with Todd Cain, who is the Executive Director of Market Development for HC. Within this market development process, things appear to be mostly on point, and Health Canada appears to be honoring and adhering to agreements. The process seems to have a measurable momentum. But once the Licensing and Permits division has to issue the license in accordance with active agreements and requirements which the applicant has met, this office begins asking for additional requirements, extending the deadline, and the licensing never happens. The company is ignored and begins to be seriously harassed and defamed by outside sources.
I find it worth noting that the timeline of events matches precisely with a chart from one of our previous articles. When the time to issue this license appears to have arrived for the Office of Controlled Substances (who issues the licenses), Jacinthe David involvement seems to coincide with the timeline of heavy attacks on the company’s image through certain media outlets. You can see this chart posted in a previous article on Canadian Cannabis Corruption in which to date, approximately 80 negative articles have surfaced since the beginning of May, 2014, and from only a few specific media personalities, of which some had direct communications or involvement with anti-MMPR proponent Libby Davies of the Canadian NDP. We do not yet know if this timeline is purely extreme coincidence.
However, we do know at a minimum that this particular MMPR applicant CEN Biotech Inc., and other applicants, have been treated unfairly by this office, and that that the Office of Controlled Substances’ inability to follow through with agreed upon licensing, has caused both significant damage to the reputation and credibility of CEN Biotech Inc. and also allowed opponents to discredit the company through Health Canada’s actions and/or lack of. It will be interesting to see Health Canada officials and files of licensed producers deposed and subpoenaed to compare their overall treatment in comparison to CEN Biotech. It does appear by these documents and MMPR regulations that the CEN Biotech license should have been issued immediately after clearance was successful pursuant to Section 25 which states …“Must issue”.
In fact, CEN Biotech states that not only may their Charter Rights be infringed upon by a lack of decision by the minister of Health, but that blanket arguments and delays bearing similar tactics of arguments are also raised in Allard v Canada, and that a history of unjust refusal of applicants, at times even without notice, brings to light an issue of unjust prejudice against other MMPR applicants. CEN Biotech is seeking discovery within the MMPR process to showcase the failure to provide a cohesive approach to building readiness and license issuance post inspection. I believe other MMPR applicants who have faced similar challenges should thoroughly appreciate these actions.
It other jurisdictions, such as Nevada, a Marijuana cultivation license is issued prior to build out, whereas in this case, there seems to exist a prevalent opportunity for both system and applicant abuse, allowing for repetitive loopholes in the effectiveness of the systems implementation. ~ http://www.mmj.today/cen-biotech-files-application-for-judicial-review/
FEDERAL COURT ~ FILING T-262-15 - February 20, 2015:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111040616
$FITX
If/When....Spin Off by then ?
It's time to clean house...
To be licensed or not...that's the question.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111040616
$FITX